Variation in the TNF Gene Promoter and Risk of Osteolysis After Total Hip Arthroplasty

Journal of Bone and Mineral Research

Volumn 18, Issue 11, 2003, Pages 1995-2001

  Wilkinson, J Mark ^a   Wilson, A Gerard ^a   Stockley, Ian ^b   Scott, Ian R ^c   Macdonald, David A ^d   Hamer, Andrew J ^b   Duff, Gordon W ^a   Eastell, Richard ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

^c CHESTERFIELD ROYAL HOSPITAL   (United Kingdom)

^d ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Association; Cytokines; Implants; Osteolysis; Polymorphism; Polymorphisms; Population studies; Total hip arthroplasty; Tumor necrosis factor

Indexed keywords

GENOMIC DNA;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; IMPLANT; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PREVALENCE; PROMOTER REGION; PROSTHESIS FAILURE; RISK FACTOR; TOTAL HIP PROSTHESIS; TUMOR NECROSIS FACTOR GENE;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ENVIRONMENT; FEMALE; GENE FREQUENCY; GENOTYPE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OSTEOLYSIS; PROMOTER REGIONS (GENETICS); RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; VARIATION (GENETICS);

EID: 0242496251     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.11.1995     Document Type: Article

References (38)

1. Hawker GA, Wright JG, Coyte PC, Williams JI, Harvey B, Glazier R, Badley EM 2000 Differences between men and women in the rate of use of hip and knee arthroplasty. N Engl J Med 342:1016-1022.
2. Herberts P, Malchau H 2000 Long-term registration has improved the quality of hip replacement: A review of the Swedish THR Register comparing 160, 000 cases. Acta Orthop Scand 71:111-121.
3. Wright TM, Goodman SB 2002 Clinical issues: What is the scope of implant wear in the hip and how has it changed since 1995? In: Wright TM, Goodman SB (eds.) Implant Wear in Total Joint Replacement, 1st ed. American Academy of Orthopaedic Surgeons, Rosemont, IL, USA, pp. 3-7.
4. Malchau H, Herberts P, Ahnfelt L 1993 Prognosis of total hip replacement in Sweden. Follow up of 92, 675 operations performed 1978-1990. Acta Orthop Scand 64:497-506.
5. Goldring SR, Schiller AL, Roelke M, Rourke CM, O'Neill DA, Harris WH 1983 The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 65:575-584.
6. Perez RE, Rodriguez JA, Deshmukh RG, Ranawat CS 1998 Polyethylene wear and periprosthetic osteolysis in metal-backed acetabular components with cylindrical liners. J Arthroplasty 13:1-7.
7. Archibeck MJ, Jacobs JJ, Roebuck K, Glant TT 2001 The basic science of periprosthetic osteolysis. In: Sim FH (ed.) Instructional Course Lectures, 51st ed. American Academy of Orthopaedic Surgeons, Rosemont, IL, pp. 185-195.
8. Chiba J, Rubash HE, Kim KJ, Iwaki Y 1994 The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis. Clin Orthop 300:304-312.
9. Kim KJ, Hijikata H, Itoh T, Kumegawa M 1998 Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices. J Biomed Mater Res 43:234-240.
10. Nakashima Y, Sun D-H, Trindade M, Maloney WJ, Goodman SB, Schurman DJ, Smith R 1999 Signaling pathways for tumour necrosis factor-α and interleukin-6 expression in human macrophages exposed to titanium-alloy particulate debris in vitro. J Bone Joint Surg Am 81:603-615.
11. Ingham E, Green TR, Stone MH, Kowalski R, Watkins N, Fisher J 2000 Production of TNF-alpha and bone resorbing activity by macrophages in response to different types of bone cement particles. Biomaterials 21:1005-1013.
12. Haynes DR, Boyle SJ, Rogers SD, Howie DW, Vernon R 1998 Variation in cytokines induced by particles from different prosthetic materials. Clin Orthop 352:223-230.
13. Merkel KD, Erdmann JM, McHugh KP, Abu-Amer Y, Ross FP, Teitelbaum SL 1999 Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am J Pathol 154:203-210.
14. Schwarz EM, Lu AP, Goater JJ, Benz EB, Kollias G, Rosier RN, Puzas JE, O'Keefe RJ 2000 Tumor necrosis factor-alpha/nuclear transcription factor-kappaB signaling in periprosthetic osteolysis. J Orthop Res 18:472-480.
15. Childs LM, Goater JJ, O'Keefe RJ, Schwartz EM 2001 Efficacy of etanercept for wear debris-induced osteolysis. J Bone Miner Res 16:338-347.
16. Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL 1986 Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83:8699-8702.
17. Hajeer AH, Hutchinson IV 2000 TNF-alpha gene polymorphism: Clinical and biological implications. Microsc Res Tech 50:216-228.
18. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D 1994 Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508-510.
19. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C 1998 Tumor necrosis factor alpha promoter polymorphism at position-238 is associated with chronic active hepatitis C infection. J Med Virol 54:173-177.
20. Arias Al, Giles B, Eiermann TH, Sterry W, Pandey JP 1997 Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp Clin Immunogenet 14:118-122.
21. Harris WH, McGann WA 1986 Loosening of the femoral component after use of the medullary-plug cementing technique. Follow-up note with a minimum five-year follow-up. J Bone Joint Surg Am 68:1064-1066.
22. Harris WH, Penenberg BL 1987 Further follow-up on socket fixation using a metal-backed acetabular component for total hip replacement. A minimum ten-year follow-up study. J Bone Joint Surg Am 69:1140-1143.
23. Wilkinson JM, Hamer AJ, Elson RA, Stockley I, Eastell R 2002 Precision of Ebra-Digital software for monitoring implant migration after total hip arthroplasty. J Arthroplasty 17:910-925.
24. Lee LG, Connell CR, Bloch W 1993 Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res 21:3761-3766.
25. Zhao JH, Curtis D, Sham PC 2000 Model-free analysis and permutation tests for allelic associations. Hum Hered 50:133-139.
26. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi, PM 1995 Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol 42:501-504.
27. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW 1997 Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199.
28. Altman DG 1991 Clinical trials. In: Altman DG (ed.) Practical Statistics for Medical Research, 1st ed. Chapman and Hall, London, UK, pp. 440-476.
29. Ilchmann T, Markovic L, Joshi A, Hardinge K, Murphy J, Wingstrand H 1998 Migration and wear of long-term successful Charnley total hip replacements. J Bone Joint Surg B 80:377-381.
30. Herberts P, Malchau H 1997 How outcome studies have changed total hip arthroplasty practices in Sweden. Clin Orthop 344:44-60.
31. D'Alfonso S, Richiardi PM 1994 A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150-154.
32. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW 1993 An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177:557-560.
33. Fitzpatrick R, Shortall E, Sculpher M, Murray D, Morris R, Lodge M, Dawson J, Carr A, Britton A, Briggs A 1998 Primary total hip replacement surgery: A systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses. Health Technology Assessment (Winchester, England) 2:1-64.
34. Faulkner A, Kennedy LG, Baxter K, Donovan J, Wilkinson M, Bevan G 1998 Effectiveness of hip prostheses in primary total hip replacement: A critical review of evidence and an economic model. Health Technol Assess 2:1-133.
35. Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM 2001 The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis. J Bone Joint Surg Br 83:902-911.
36. Kornman KS, di Giovine FS 1998 Genetic variations in cytokine expression: A risk factor for severity of adult periodontitis. Ann Periodontol 3:327-338.
37. Keen RW, Woodford-Richens KL, Lanchbury JS, Spector TD 1998 Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone 23:367-371.
38. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286.